Aisling Capital Partners III LLC, 10% Owner, Director at Loxo Oncology, Inc. (LOXO), sold 250,000 shares at $80.50 ($20.1M) on 2017-12-19, disclosed to the SEC on 2017-12-20.
Open-market sale of $20.1M LOXO by 10% Owner, Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TTOO | BUY | 2015-12-09 | $3.0M | — | Filing → |
| LOXO | BUY | 2015-11-19 | $7.0M | — | Filing → |
| LOXO | BUY | 2015-11-16 | $2.2M | — | Filing → |